Cachexia - An intrinsic factor in wound healing

International Wound Journal

Volumn 7, Issue 2, 2010, Pages 107-113

  Michael Fy, Ng ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Cachexia; Collagen deposition; Inflammation; Reepithelialisation; Wound healing

Indexed keywords

COLLAGEN; GELATINASE A; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CACHEXIA; COLLAGEN METABOLISM; ENZYME ACTIVITY; EPITHELIZATION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; WOUND HEALING;

BIOSYNTHETIC PATHWAYS; CACHEXIA; COLLAGEN; CYTOKINES; FIBROBLASTS; HUMANS; INFLAMMATION; NITRIC OXIDE SYNTHASE; WOUND HEALING;

EID: 77951217905     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2010.00663.x     Document Type: Review

References (55)

1. Broughton G IInd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006 117 : 12S 34S.
2. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 1993 100 : 721 725. (Pubitemid 23128373)
3. Halloran CM, Slavin JP. Pathophysiology of wound healing. Surgery 2002 20 : i v.
4. Kotler DP. Cachexia. Ann Intern Med 2000 133 : 622 634.
5. Woolf N. Pathology: basic and systemic, 1st edn.
6. Sedlarik KM, Piatek S, Reusche S, Lippert H. Impaired wound healing as a result of systemic diseases. J Wound Care 1995 4 : 119 120.
7. Enoch S, Leaper DJ. Basic science of wound healing. Surgery 2005 23 : 37 42. (Pubitemid 40435388)
8. Hart J. Inflammation. 1: its role in the healing of acute wounds. J Wound Care 2002 11 : 205 209.
9. Durham WJ, Dillon EL, Sheffield-Moore M. Inflammatory burden and amino acid metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care 2009 12 : 72 7.
10. NCBI IL6 interleukin 6 (interferon, beta 2) [Homo sapiens] [online]. Entrez Gene. 13 August 2009. Available at: http://www.ncbi.nlm.nih.gov/sites/ entrez?Db=gene&Cmd=retrieve&dopt=full-report&list-uids= 3569&log$=genesensor4&logdbfrom=pubmed [accessed on 16 August 2009].
11. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000 14 : 2525 2531.
12. Luckett LR, Gallucci RM. Interleukin-6 (IL-6) modulates migration and matrix metalloproteinase function in dermal fibroblasts from IL-6KO mice. Br J Dermatol 2007 156 : 1163 1171.
13. van Oers MH, van der Heyden AA, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988 71 : 314 319. (Pubitemid 18065787)
14. Mokart D, Capo C, Blache JL, Delpero JR, Houvenaeghel G, Martin C, Mege JL. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002 89 : 1450 1456.
15. Mei YQ, Ji Q, Liu H, Wang X, Feng J, Long C, Cheng B, Xing Y, Li J, Hu D. Study on the relationship of APACHE III and levels of cytokines in patients with systemic inflammatory response syndrome after coronary artery bypass grafting. Biol Pharm Bull 2007 30 : 410 414. (Pubitemid 46355912)
16. Hunt TK, Hopf HW. Wound healing and wound infection. What surgeons and anesthesiologists can do. Surg Clin North Am 1997 77 : 587 606.
17. Min/+ mice. Am J Physiol Regul Integr Comp Physiol 2008 294 : R393 401.
18. Jamieson NB, Brown DJ, Michael Wallace A, McMillan DC. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine 2004 27 : 90 2.
19. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients. Clin Biochem 2007 40 : 1353 1360. (Pubitemid 350151421)
20. Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Murai M. Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology 2007 69 : 113 117. (Pubitemid 46161697)
21. Witte KK, Ford SJ, Preston T, Parker JD, Clark AL. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol 2008 129 : 363 367.
22. Deans DA, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC. Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 2009 89 : 1164 1172.
23. Morley JE, Farr SA. Cachexia and neuropeptide Y. Nutrition 2008 24 : 815 819.
24. Muangman P, Tamura RN, Muffley LA, Isik FF, Scott JR, Xie C, Kegel G, Sullivan SR, Liang Z, Gibran NS. Substance P enhances wound closure in nitric oxide synthase knockout mice. J Surg Res 2009 153 : 201 209.
25. Bove PF, Wesley UV, Greul AK, Hristova M, Dostmann WR, van der Vliet, A. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 2007 36 : 138 146. (Pubitemid 46233465)
26. Bell RR, Dunstan RW, Khan NK. Skin wound healing in the SKH-1 female mouse following inducible nitric oxide synthase inhibition. Br J Dermatol 2007 157 : 656 661.
27. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, Usui ML, Larsen J, Smith DG, Burnett N, Ansel JC, Olerud JE. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002 108 : 122 128. (Pubitemid 35373824)
28. Nishida T, Chikama T, Morishige N, Yanai R, Yamada N, Saito J. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P-derived peptide and insulin-like growth factor 1. Jpn J Ophthalmol 2007 51 : 442 447.
29. Hardman MJ, Ashcroft GS. Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly. Genome Biology 2008 9 : R80 [Online] Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=2441466 [Accessed on 29 April 2009].
30. Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005 2 : CD004310.
31. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 1996 15 : 1753 1765. (Pubitemid 26119211)
32. Wang W, Svanberg E, Delbro D, Lundholm K. NOS isoenzyme content in brain nuclei as related to food intake in experimental cancer cachexia. Brain Res Mol Brain Res 2005 134 : 205 214. (Pubitemid 40504137)
33. Vitale A, Manciocco A, Alleva E. The 3R principle and the use of non-human primates in the study of neurodegenerative diseases: the case of Parkinson's disease. Neurosci Biobehav Rev 2009 33 : 33 47.
34. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985 316 : 552 554. (Pubitemid 16239366)
35. Kähäri VM, Chen YQ, Su MW, Ramirez F, Uitto J. Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J Clin Invest 1990 86 : 1489 1495. (Pubitemid 20372595)
36. Greenwel P, Tanaka S, Penkov D, Zhang W, Olive M, Moll J, Vinson C, Di Liberto M, Ramirez F. Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol Cell Biol 2000 20 : 912 918. (Pubitemid 30044228)
37. Chojkier M, Spanheimer R, Peterkofsky B. Specifically decreased collagen biosynthesis in scurvy dissociated from an effect on proline hydroxylation and correlated with body weight loss. In vitro studies in guinea pig calvarial bones. J Clin Invest 1983 72 : 826 835. (Pubitemid 14211392)
38. Chojkier M, Flaherty M, Peterkofsky B, Majmudar GH, Spanheimer RG, Brenner DA. Different mechanisms decrease hepatic collagen and albumin production in fasted rats. Hepatology 1988 8 : 1040 1045.
39. Buck M, Houglum K, Chojkier M. Tumour necrosis factor-α inhibits collagen α1(I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996 149 : 195 204. (Pubitemid 26230991)
40. Cowin AJ, Hatzirodos N, Rigden J, Fitridge R, Belford DA. Etanercept decreases tumor necrosis factor-α activity in chronic wound fluid. Wound Repair Regen 2006 14 : 421 426. (Pubitemid 44266598)
41. Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-α (TNF-α) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004 279 : 32633 32642. (Pubitemid 39014721)
42. Corrao S, Pistone G, Arnone S, Calvo L, Scaglione R, Licata G. Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. Clin Rheumatol 2007 26 : 1513 1515. (Pubitemid 47193569)
43. Greenhalgh T. How to read a paper. Getting your bearings (deciding what the paper is about). BMJ 1997 315 : 243 246. (Pubitemid 27326334)
44. Ruyssen-Witrand A, Gossec L, Salliot C, Luc M, Duclos M, Guignard S, Dougados M. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 2007 25 : 430 436. (Pubitemid 47091020)
45. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006 84 : 1463 1472. (Pubitemid 44912832)
46. Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008 44 : 1124 1132.
47. McAnulty RJ. Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 2007 39 : 666 671.
48. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 2005 304 : 274 286. (Pubitemid 40222094)
49. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signalling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005 16 : 73 8.
50. Hubner G, Hu Q, Smola H, Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 1996 173 : 490 498. (Pubitemid 26064869)
51. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, Evans LW, Huylebroeck D, Balling R, Werne S. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999 18 : 5205 5215. (Pubitemid 29465571)
52. Wankell M, Munz B, Hubner G, Hans W, Wolf E, Goppelt A, Werner S. Impaired would healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 2001 20 : 5361 5372. (Pubitemid 32959456)
53. Fumagalli M, Musso T, Vermi W, Scutera S, Daniele R, Alotto D, Cambieri I, Ostorero A, Gentili F, Caposio P, Zucca M, Sozzani S, Stella M, Castagnoli C. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol 2007 16 : 600 610. (Pubitemid 46958566)
54. Li Q, Kumar R, Underwood K, O'Connor AE, Loveland KL, Seehra JS, Matzuk MM. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein. Mol Hum Reprod 2007 13 : 675 683. (Pubitemid 47354915)
55. Costelli P, Muscaritoli M, Bonetto A, Penna F, Reffo P, Bossola M, Bonelli G, Doglietto GB, Baccino FM, Rossi Fanelli F. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest 2008 38 : 531 538. (Pubitemid 351832040)